Why young scientists may hold the key to a cancer cure
Early- and mid-career scientists face tougher odds than their more-experienced colleagues, which can be discouraging for young creative minds looking for a chance to fight cancer. Meet Paul Northcott, a 40-year-old investigator from St. Jude Children's Research Hospital who knows firsthand how early grant money can impact innovative cancer research.
Comments